Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7.97M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
1.15M
-
Shares change
-
+1.15M
-
Total reported value, excl. options
-
$8.67M
-
Value change
-
+$8.67M
-
Number of buys
-
25
-
Price
-
$7.55
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q3 2025
26 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q3 2025.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.15M shares
of 7.97M outstanding shares and own 14.42% of the company stock.
Largest 10 shareholders include Telemark Asset Management, LLC (414K shares), VANGUARD GROUP INC (182K shares), PERCEPTIVE ADVISORS LLC (109K shares), Monashee Investment Management LLC (100K shares), PERKINS CAPITAL MANAGEMENT INC (52.6K shares), SILVERARC CAPITAL MANAGEMENT, LLC (49.6K shares), GSA CAPITAL PARTNERS LLP (48.3K shares), Balyasny Asset Management L.P. (43K shares), GEODE CAPITAL MANAGEMENT, LLC (40.2K shares), and BlackRock, Inc. (24.5K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.